Olympus (TSE:7733) Net Income From Continuing Operations : 円384,130 Mil (TTM As of Mar. 2024)

View and export this data going back to 1949. Start your Free Trial

What is Olympus Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Olympus's net income from continuing operations for the three months ended in Mar. 2024 was 円2,998 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2024 was 円384,130 Mil.

Olympus Net Income From Continuing Operations Historical Data

The historical data trend for Olympus's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Olympus Net Income From Continuing Operations Chart

Olympus Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Net Income From Continuing Operations

Get a 7-Day Free Trial

77,798.00

24,334.00

149,873.00

189,707.00

384,130.00

Olympus Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Income From Continuing Operations	Get a 7-Day Free Trial															48,403.00	367,338.00	-20,114.00	33,908.00	2,998.00

Olympus Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円384,130 Mil.

Olympus (TSE:7733) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Olympus Corp (TSE:7733) » Definitions » Net Income From Continuing Operations

Comparable Companies

Traded in Other Exchanges

OLYMY:USA OCPNF:USA OLY1:Germany

Address

Shinjuku Monolith, 2-3-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo, JPN, 163-0914

Website

http://www.olympus.co.jp

Olympus Corp manufactures and sells precision instruments for the healthcare industry. The firm operates in three segments: scientific solutions, imaging, and medical. The scientific solutions segment sells microscopes and other imaging tools to life sciences and industrial customers. The imaging segment sells digital cameras under the Olympus brand. The medical segment supplies medical equipment, including gastrointestinal and surgical endoscopes and endotherapy devices. This segment generates the vast majority of revenue. Sales in Asia and North America contribute the largest proportions of revenue.

Olympus (TSE:7733) Headlines

No Headlines